Pricing Log in Create free account

Moderna, Inc. (MRNA) vs Revolution Medicines, Inc. (RVMD)

Moderna, Inc. and Revolution Medicines, Inc. are both Biotechnology companies. Moderna, Inc. is the larger, with a market value of $94.4B against $40.6B — 2.3× the size. Revolution Medicines, Inc. grew revenue faster over the last twelve months: −8.81% against −27.6%. Revolution Medicines, Inc. has the higher net margin (0.00% vs −141.4%) and the higher return on invested capital (0.00% vs −93.5%). Across the 18 metrics below, Moderna, Inc. leads on 10 and Revolution Medicines, Inc. on 8.

Valuation

Metric MRNA RVMD Biotechnology median
P/E n/m n/m 8.50
P/S 38.94 1,394.67 9.71
P/B 12.83 14.40 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 36.91 1,286.83 9.21
Earnings yield (3.66%) (4.96%) (33.15%)
Free cash flow yield (1.43%) (3.28%) (25.50%)

Profitability

Metric MRNA RVMD Biotechnology median
Gross margin 23.38% 35.06% 65.16%
Operating margin (149.01%) 0.00% 0.00%
Net margin (141.43%) 0.00% 0.00%
Free cash flow margin (55.83%) 0.00% 0.00%
Return on equity (39.00%) (79.09%) (56.36%)
Return on assets (27.43%) (52.37%) (48.04%)
Return on invested capital (93.47%) 0.00% 0.00%

Growth

Metric MRNA RVMD Biotechnology median
Revenue growth (TTM) (27.62%) (8.81%) 6.02%
EPS growth (last fiscal year) 21.77% (66.20%) 30.26%
Revenue growth, 5-year CAGR 19.34% (10.50%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MRNA RVMD Biotechnology median
Debt to equity 0.09 0.40 0.00
Current ratio 2.29 11.38 4.72
Net debt to EBITDA 1.77 1.47 0.96

Dividend

Metric MRNA RVMD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MRNA RVMD Biotechnology median
Market cap 94.42b 40.57b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack